WallStSmart

LifeMD Inc (LFMD)vsTempus AI, Inc. Class A Common Stock (TEM)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Tempus AI, Inc. Class A Common Stock generates 647% more annual revenue ($1.43B vs $191.59M). LFMD leads profitability with a 0.1% profit margin vs -17.8%. TEM earns a higher WallStSmart Score of 28/100 (F).

LFMD

Avoid

26

out of 100

Grade: F

Growth: 4.7Profit: 2.5Value: 5.0Quality: 3.5
Piotroski: 3/9Altman Z: -1.73

TEM

Avoid

28

out of 100

Grade: F

Growth: 7.3Profit: 2.0Value: 5.0Quality: 5.0
Piotroski: 4/9Altman Z: -0.65

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

LFMD0 strengths · Avg: 0/10

No standout strengths identified

TEM1 strengths · Avg: 8.0/10
Revenue GrowthGrowth
21.6%8/10

Revenue surging 21.6% year-over-year

Areas to Watch

LFMD4 concerns · Avg: 3.5/10
Price/BookValuation
17.9x4/10

Trading at 17.9x book value

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$147.01M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
0.1%3/10

0.1% margin — thin

TEM4 concerns · Avg: 2.5/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Price/BookValuation
23.9x2/10

Trading at 23.9x book value

Return on EquityProfitability
-57.2%2/10

ROE of -57.2% — below average capital efficiency

Free Cash FlowQuality
$-18.62M2/10

Negative free cash flow — burning cash

Comparative Analysis Report

WallStSmart Research

Bull Case : LFMD

LFMD has a balanced fundamental profile.

Bull Case : TEM

The strongest argument for TEM centers on Revenue Growth. Revenue growth of 21.6% demonstrates continued momentum.

Bear Case : LFMD

The primary concerns for LFMD are Price/Book, EPS Growth, Market Cap. Thin 0.1% margins leave little buffer for downturns.

Bear Case : TEM

The primary concerns for TEM are EPS Growth, Price/Book, Return on Equity. Debt-to-equity of 3.25 is elevated, increasing financial risk.

Key Dynamics to Monitor

LFMD profiles as a value stock while TEM is a growth play — different risk/reward profiles.

TEM carries more volatility with a beta of 3.72 — expect wider price swings.

TEM is growing revenue faster at 21.6% — sustainability is the question.

LFMD generates stronger free cash flow (-11M), providing more financial flexibility.

Bottom Line

TEM scores higher overall (28/100 vs 26/100) and 21.6% revenue growth. Both earn "Avoid" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

LifeMD Inc

HEALTHCARE · HEALTH INFORMATION SERVICES · USA

LifeMD, Inc. is a direct-to-patient telehealth company connecting consumers with healthcare professionals for care in various indications, including concierge care, men's sexual health, dermatology, and others in the United States. . The company is headquartered in New York, New York.

Tempus AI, Inc. Class A Common Stock

HEALTHCARE · HEALTH INFORMATION SERVICES · USA

Tempus AI, Inc is a healthcare technology company. The company is headquartered in Chicago, Illinois.

Visit Website →

Want to dig deeper into these stocks?